<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00791466</url>
  </required_header>
  <id_info>
    <org_study_id>MITCH-01</org_study_id>
    <nct_id>NCT00791466</nct_id>
  </id_info>
  <brief_title>Maternal Iodine Supplementation and Effects on Thyroid Function and Child Development</brief_title>
  <acronym>MITCH</acronym>
  <official_title>Iodine Supplementation in Pregnant Women Living in Mild-to-moderately Iodine Deficient Areas in India and Thailand: Effects on Pregnancy Outcome and Infant Development</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wageningen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. John's Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Unilever R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Swiss National Science Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nestlé Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wageningen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: In regions of severe endemic goiter, the adverse effects of in utero iodine
      deficiency on neuromotor development are well established: randomized controlled trials of
      iodine supplements given to iodine deficient mothers before pregnancy or during early
      pregnancy improve motor and cognitive performance of their offspring. However, the potential
      adverse effects of mild-to-moderate iodine deficiency during pregnancy are unclear.
      Inadequate thyroid function in the fetus and newborn are the likely cause of brain damage in
      iodine deficiency.

      Objective: To determine whether the daily oral administration of 200 µg iodine to pregnant
      women in areas of mild-to-moderate iodine deficiency improves maternal and newborn thyroid
      function, pregnancy outcome, birth weight, infant growth and cognitive performance.

      Study design: Double-blind randomized controlled multicentre trial. Study population:
      Pregnant women (18-40 years) presenting at the clinic for their first prenatal visit will be
      recruited at two research sites, namely St. Martha's hospital in Bangalore, India and
      Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. At each site, 400 women will be
      recruited.

      Intervention: Half of the women will be randomized to iodine treatment (200 µg per day) and
      the other half to placebo throughout pregnancy.

      Main study parameters/endpoints: Differences between group means in indicators of thyroid
      function, birth outcome, urinary iodine, breast milk iodine, infant growth, and psychomotor
      development.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Current primary outcome: Infant cognitive and motor development</measure>
    <time_frame>Regular intervals up till 6 years of age</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Original primary outcome: Maternal thyroid function</measure>
    <time_frame>3-month intervals during pregnancy, at delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Birth outcome</measure>
    <time_frame>At delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal and infant urinary iodine</measure>
    <time_frame>Regular intervals during pregnancy up till 2 years after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breast milk iodine</measure>
    <time_frame>3 and 6 months after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long-term follow up</measure>
    <time_frame>Child age 2-6 years</time_frame>
    <description>Anthropometrics, urinary iodine, thyroid hormones, WPPS, BRIEF-P, hearing thresholds</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">829</enrollment>
  <condition>Iodine Deficiency</condition>
  <condition>Infant Development</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Daily placebo supplementation from enrolment &lt;14 wk of gestation until delivery</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Iodine</intervention_name>
    <description>Daily supplementation with 200 µg iodine from enrolment &lt;14 wk of gestation until delivery</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-40 years;

          -  Gestational age: ≤ 14 weeks (as judged by the date of the last menstrual period);

          -  Single pregnancy;

          -  Non-lactating;

          -  Planned residence in the area for the duration of the study (3 years).

        Exclusion Criteria:

          -  TSH levels outside the normal range

          -  History of serious medical conditions such as HIV, hypertension, diabetes, renal,
             hepatic or cardiovascular disease, thyroid disorders, mental disorders;

          -  Use of iodine supplement.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Zimmermann, Prof. dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wageningen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alida Melse-Boonstra, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wageningen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Johns Medical College and Research Institute</name>
      <address>
        <city>Bangalore</city>
        <zip>560034</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Insitute of Nutrition, Mahidol University (INMU)</name>
      <address>
        <city>Bangkok</city>
        <zip>73170</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Melse-Boonstra A, Gowachirapant S, Jaiswal N, Winichagoon P, Srinivasan K, Zimmermann MB. Iodine supplementation in pregnancy and its effect on child cognition. J Trace Elem Med Biol. 2012 Jun;26(2-3):134-6. doi: 10.1016/j.jtemb.2012.03.005. Epub 2012 May 8.</citation>
    <PMID>22575544</PMID>
  </reference>
  <reference>
    <citation>Gowachirapant S, Melse-Boonstra A, Winichagoon P, Zimmermann MB. Overweight increases risk of first trimester hypothyroxinaemia in iodine-deficient pregnant women. Matern Child Nutr. 2014 Jan;10(1):61-71. doi: 10.1111/mcn.12040. Epub 2013 Aug 13.</citation>
    <PMID>23937433</PMID>
  </reference>
  <reference>
    <citation>Jaiswal N, Melse-Boonstra A, Thomas T, Basavaraj C, Sharma SK, Srinivasan K, Zimmermann MB. High prevalence of maternal hypothyroidism despite adequate iodine status in Indian pregnant women in the first trimester. Thyroid. 2014 Sep;24(9):1419-29. doi: 10.1089/thy.2014.0071. Epub 2014 Jul 21.</citation>
    <PMID>24923842</PMID>
  </reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 13, 2008</study_first_submitted>
  <study_first_submitted_qc>November 13, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 14, 2008</study_first_posted>
  <last_update_submitted>November 16, 2016</last_update_submitted>
  <last_update_submitted_qc>November 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wageningen University</investigator_affiliation>
    <investigator_full_name>Alida Melse</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Iodine deficiency</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Thyroid function</keyword>
  <keyword>Infant development</keyword>
  <keyword>Growth</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iodine</mesh_term>
    <mesh_term>Cadexomer iodine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

